Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 2931 of 5804
-
Monthly MS injection aims to halt disability progression
Disease control TerminatedThis is a phase IIa study with GA Depot in subjects with Primary Progressive MS. GA Depot will be administered intramuscularly (IM), once every four weeks for 148 weeks. The purpose of this study is to assess the safety and efficacy of GA Depot to slow the accumulation of disabi…
Phase: PHASE2 • Sponsor: Mapi Pharma Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Can genes predict COPD attacks? new study seeks answers
Knowledge-focused Recruiting nowExacerbations of chronic obstructive pulmonary disease (COPD) are unfavourable events in the course of disease for most COPD patients. Published evidence indicates a significant impact of exacerbations, especially if frequent, on patients' health-related quality of life (HRQL), d…
Sponsor: Xinhua Hospital, Shanghai Jiao Tong University School of Medicine • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:00 UTC
-
Radiation and immunotherapy combo tested for lung cancer
Disease control TerminatedThis investigator driven Phase Ib study will examine the safety, efficacy and biological effects of two schedules of pembrolizumab, an antibody targeted against anti-programmed cell death 1 (PD-1), which will be given either before or after stereotactic ablative body radiotherapy…
Phase: PHASE1 • Sponsor: Peter MacCallum Cancer Centre, Australia • Aim: Disease control
Last updated Jun 26, 2026 17:11 UTC
-
Immunotherapy drug tested for rare blood cancers
Disease control TerminatedThis research study is studying a drug called pembrolizumab as a possible treatment for aggressive lymphoma or a histiocyte or dendritic cell neoplasm. The drug involved in this study is: -Pembrolizumab
Phase: PHASE2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
Brain scans reveal Lithium's secret workings in bipolar depression
Knowledge-focused CompletedLithium is highly effective in the treatment of bipolar disorder. This study aims to investigate, for the first time, the impact of lithium monotherapy on the structural and functional connectivity of the brain using MRI imaging.
Sponsor: Brigham and Women's Hospital • Aim: Knowledge-focused
Last updated Jul 18, 2026 00:00 UTC
-
New immunotherapy combo shows promise for advanced cancers
Disease control CompletedThe purpose of this study is to determine whether BMS-986249 both by itself and in combination with Nivolumab is safe and tolerable in the treatment of advanced solid tumors
Phase: PHASE1, PHASE2 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
New MRI scan could reveal hidden clues about brain tumor behavior
Knowledge-focused Recruiting nowUpwards of 40% of cancer patients will develop brain metastases during their illness, most of which become symptomatic. The burden of brain metastases impacts the quality and length of survival. Thus the management of brain metastases is a significant health care problem. Standar…
Phase: PHASE1 • Sponsor: Sunnybrook Health Sciences Centre • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC
-
Can a common steroid help cancer patients breathe easier?
Symptom relief OngoingThis phase II trial studies how well dexamethasone works in controlling dyspnea in patients with cancer. Dexamethasone may help control dyspnea (shortness of breath) and improve lung function and quality of life in cancer patients.
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated Jun 27, 2026 13:07 UTC
-
Dissolving heart scaffolds put to the test in massive Real-World study
Disease control Recruiting nowThe prospective study will investigate the clinical performance and long-term safety of scaffold implantation in a real world regional setting. The protocol includes two different networks. The first network includes all cath-labs in the Emilia-Romagna region (SHERPA). The second…
Sponsor: University Hospital of Ferrara • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Mindfulness calms the storm: new hope for angry veterans
Symptom relief CompletedResearch has consistently shown that Veterans with PTSD are more likely to experience higher levels of anger and commit aggressive acts compared to Veterans without PTSD. Given the significant negative impact that anger and aggression can have on the lives of Veterans, their fami…
Phase: NA • Sponsor: VA Office of Research and Development • Aim: Symptom relief
Last updated Jun 27, 2026 12:28 UTC
-
Shock and shake: new combo therapy aims to rebuild muscle after brain bleed
Disease control Recruiting nowThe study purpose is to investigate the hypothesis that in adults with SAH, early neuromuscular electrical stimulation (NMES) and high protein supplementation (HPRO) will improve muscle mass, metabolic and inflammatory biomarker profiles, compared to SAH controls receiving standa…
Phase: NA • Sponsor: University of Maryland, Baltimore • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Diabetes drug may boost heart fuel use in patients with clogged arteries
Disease control CompletedA Phase III, single-centre, randomized, 2-arm, parallel-group, double blind, placebo-controlled study, consisting of a screening phase (Days -14 to -1), a 4-week double-blind, placebo-controlled treatment phase and a 4-week follow-up phase. Subjects: Type 2 diabetic patients and…
Phase: PHASE3 • Sponsor: Giaccari Andrea • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Joystick training may boost smoking cessation success
Symptom relief CompletedTobacco use is the most preventable cause of disease, disability, and death in the United States. Standard smoking cessation care (cognitive behavioral therapy and nicotine replacement therapy), is effective in approximately 20% of the cases, clearly indicating there is substanti…
Phase: NA • Sponsor: Jasper A. Smits • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Can facebook find you a kidney? new study tests social media for organ donors
Knowledge-focused Recruiting nowThis study utilizes a web-based application to help patients on the organ transplant waitlist communicate patient's need for a living donor via social media and provide interested potential donors the opportunity to engage with the evaluation process.
Phase: NA • Sponsor: Johns Hopkins University • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:56 UTC
-
New drug cocktail aims to tame Hard-to-Treat breast cancer
Disease control OngoingThis study will evaluate the safety, pharmacokinetic (PK), pharmacodynamic (PD) activity, and preliminary anti-tumor activity of GDC-9545 as a single agent and in combination with palbociclib and/or luteinizing hormone-releasing hormone (LHRH) agonist in participants with advance…
Phase: PHASE1 • Sponsor: Genentech, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Immune cells may predict CMV relapse in kidney transplant patients
Disease control CompletedIn kidney transplant patients, CMV infection remains the leading infectious cause of morbidity and mortality. Clinical and virological relapses are common and are involved in chronic graft dysfunction. To date, it is not certain that secondary prophylaxis allows reducing these re…
Phase: PHASE2 • Sponsor: University Hospital, Bordeaux • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Breathing in chemo: new hope for lung metastases?
Disease control Recruiting nowAny time the words "you," "your," "I," or "me" appear, it is meant to apply to the potential participant. The goal of this clinical research study is to find the highest tolerable dose of gemcitabine that can be given by inhalation (breathing it as a mist) to patients with solid…
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
Crohn's patients in remission may ditch daily pills, study hints
Disease control OngoingThe purpose of this study is to assess whether withdrawal of aminosalicylate (5-ASA) is non-inferior to continuation of 5-ASA therapy in Crohn's disease (CD) subjects in remission.
Phase: PHASE4 • Sponsor: Alimentiv Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
New wearable goggles could help brain surgeons see tumors better
Knowledge-focused Recruiting nowGlioblastoma multiforme (GBM) and anaplastic astrocytoma (AA) are the most common primary malignant brain tumors. Survival of patients with these brain tumors is directly related to the extent of resection. Consequently, a great deal of effort has been directed at developing tech…
Sponsor: Guoqiang Yu • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:02 UTC
-
Swallow a tiny magnet: painless camera could replace endoscopy
Diagnosis Recruiting nowMagnetically controlled capsule endoscopy (MCCE) is an outstanding opportunity for the painless endoscopic screening of the esophagus and stomach before small bowel examiantion. Further improvement in patients positioning might increase the esophageal transit time of the capsule …
Sponsor: Bács-Kiskun County Teaching Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 07:53 UTC